8 Analysts Have This to Say About Agilon Health
Portfolio Pulse from Benzinga Insights
Agilon Health (NYSE:AGL) has received 8 analyst ratings in the last quarter, with 4 bullish, 3 somewhat bullish, and 1 indifferent. The average 12-month price target among these analysts is $20.5, with a high of $28.00 and a low of $12.00. This target represents a 22.14% decrease from the previous average target of $26.33. Analysts rate stocks based on research and provide guidance on performance metrics such as earnings and revenue.
December 06, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Agilon Health has a majority of bullish and somewhat bullish ratings from analysts, with an average price target of $20.5, which is down 22.14% from the previous target.
The decrease in the average price target suggests a more cautious outlook from analysts, which could lead to short-term uncertainty in the stock's performance. However, the majority of ratings are still bullish or somewhat bullish, indicating a generally positive sentiment that could mitigate negative impact.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100